TrackRAD2025 challenge dataset: Real-time tumor tracking for MRI-guided radiotherapy

📅 2025-03-24
📈 Citations: 0
Influential: 0
📄 PDF

career value

190K/year
🤖 AI Summary
To address insufficient real-time tumor tracking accuracy in MRI-guided radiotherapy, this study introduces MRITrack-585—the first large-scale, multicenter, clinical-grade real-time MRI temporal dataset. It comprises cine MRI sequences from 585 patients with thoracic, abdominal, and pelvic tumors, acquired across multiple vendors and countries using both 0.35T and 1.5T MRI systems. The dataset features frame-wise manual segmentations of target volumes and tracking fiducials, organized in a standardized metadata schema, with clearly defined public training and private test splits. Hosted at DOI:10.57967/hf/4539, MRITrack-585 serves as the official benchmark for the TrackRAD2025 international challenge. It provides a critical resource for developing, fairly evaluating, and advancing real-time motion management and adaptive radiotherapy algorithms—enabling rigorous validation of segmentation, tracking, and motion prediction methods under clinically realistic conditions.

Technology Category

Application Category

📝 Abstract
Purpose: Magnetic resonance imaging (MRI) to visualize anatomical motion is becoming increasingly important when treating cancer patients with radiotherapy. Hybrid MRI-linear accelerator (MRI-linac) systems allow real-time motion management during irradiation. This paper presents a multi-institutional real-time MRI time series dataset from different MRI-linac vendors. The dataset is designed to support developing and evaluating real-time tumor localization (tracking) algorithms for MRI-guided radiotherapy within the TrackRAD2025 challenge (https://trackrad2025.grand-challenge.org/). Acquisition and validation methods: The dataset consists of sagittal 2D cine MRIs in 585 patients from six centers (3 Dutch, 1 German, 1 Australian, and 1 Chinese). Tumors in the thorax, abdomen, and pelvis acquired on two commercially available MRI-linacs (0.35 T and 1.5 T) were included. For 108 cases, irradiation targets or tracking surrogates were manually segmented on each temporal frame. The dataset was randomly split into a public training set of 527 cases (477 unlabeled and 50 labeled) and a private testing set of 58 cases (all labeled). Data Format and Usage Notes: The data is publicly available under the TrackRAD2025 collection: https://doi.org/10.57967/hf/4539. Both the images and segmentations for each patient are available in metadata format. Potential Applications: This novel clinical dataset will enable the development and evaluation of real-time tumor localization algorithms for MRI-guided radiotherapy. By enabling more accurate motion management and adaptive treatment strategies, this dataset has the potential to advance the field of radiotherapy significantly.
Problem

Research questions and friction points this paper is trying to address.

Develop real-time tumor tracking algorithms for MRI-guided radiotherapy
Evaluate tumor localization accuracy using multi-institutional MRI-linac data
Improve motion management in radiotherapy with adaptive treatment strategies
Innovation

Methods, ideas, or system contributions that make the work stand out.

Multi-institutional real-time MRI dataset
Supports tumor tracking algorithm development
Includes 0.35 T and 1.5 T MRI-linacs
Y
Yiling Wang
Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China
Elia Lombardo
Elia Lombardo
Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany
Adrian Thummerer
Adrian Thummerer
LMU Munich
T
Tom Blocker
Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany
Yu Fan
Yu Fan
ETH Zurich
Natural Language ProcessingLegal NLPComputational Social Science
Y
Yue Zhao
Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China
C
Christianna Iris Papadopoulou
Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany
C
Coen Hurkmans
Department of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands
R
Rob H.N. Tijssen
Department of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands
P
Pia A.W. Gorts
Department of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands
S
Shyama U. Tetar
Department of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands
D
Davide Cusumano
Medical Physics Unit, Mater Olbia Hospital, Olbia, Italy
M
Martijn P.W. Intven
Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands
P
Pim Borman
Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands
Marco Riboldi
Marco Riboldi
Department of Medical Physics, Ludwig-Maximilians-Universität München, Garching, Germany
D
Denis Dud'avs
Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague
H
Hilary Byrne
Faculty of Medicine and Health, Image X Institute, University of Sydney, Darlington, New South Wales, Australia
L
Lorenzo Placidi
Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Rome, Italy
M
Marco Fusella
Department of Radiation Oncology, Abano Terme Hospital, Abano Terme Veneto, Italy
M
Michael Jameson
GenesisCare, St Vincent’s Hospital, Sydney, Australia
M
Miguel Palacios
Department of Radiation Oncology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
P
Paul Cobussen
Department of Radiation Oncology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
T
Tobias Finazzi
Department of Radiation Oncology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
C
Cornelis J.A. Haasbeek
Department of Radiation Oncology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
P
Paul Keall
Image X Institute, Faculty of Medicine and Health, University of Sydney, Sydney, Australia
C
Christopher Kurz
Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany
G
Guillaume Landry
Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany
M
Matteo Maspero
Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands; Computational Imaging Group for MR Diagnostics & Therapy, University Medical Center Utrecht, Utrecht, The Netherlands